Guowen Lin
Impact in
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 13
- Prostate Cancer Diagnosis and Treatment 6
-
- Cancer-related gene regulation 2
- Co-authors
- Yao Zhu (11 shared papers)Bo Dai (10 shared papers)Dingwei Ye (9 shared papers)Xiaojian Qin (9 shared papers)Junlong Wu (7 shared papers)Guohai Shi (4 shared papers)Yijun Shen (6 shared papers)Wei Yu (7 shared papers)
- Journals
- The Prostate (2 papers)Molecular Oncology (1 paper)Scientific Reports (1 paper)Cell Death Discovery (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- ChinaUnited StatesRussia
In The Last Decade
Guowen Lin
20 papers receiving 463 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 162
- Pulmonary and Respiratory Medicine 224
- Oncology 132
- Immunology 72
- Molecular Biology 207
Countries citing papers authored by Guowen Lin
This map shows the geographic impact of Guowen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guowen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guowen Lin more than expected).
Fields of papers citing papers by Guowen Lin
This network shows the impact of papers produced by Guowen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guowen Lin. The network helps show where Guowen Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Guowen Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 63 | |
| 2 | 2020 | 61 | |
| 3 | 2019 | 43 | |
| 4 | 2020 | 40 | |
| 5 | 2022 | 38 | |
| 6 | 2017 | 38 | |
| 7 | 2019 | 37 | |
| 8 | 2016 | 28 | |
| 9 | 2017 | 23 | |
| 10 | 2020 | 23 | |
| 11 | 2021 | 17 | |
| 12 | 2024 | 13 | |
| 13 | 2017 | 13 | |
| 14 | 2019 | 10 | |
| 15 | 2023 | 6 | |
| 16 | 2020 | 4 | |
| 17 | 2023 | 4 | |
| 18 | 2013 | 3 | |
| 19 | 2024 | 1 | |
| 20 | [Changes in the penis size of prostate cancer patients after radical prostatectomy and its influencing factors]. | 2021 | 1 |
About Guowen Lin
Guowen Lin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Surgery, having authored 20 papers that have together received 466 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (6 papers), Cancer, Lipids, and Metabolism (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Peptidase Inhibition and Analysis (2 papers), PARP inhibition in cancer therapy (2 papers), Cancer-related gene regulation (2 papers) and Genital Health and Disease (2 papers). The work is most often cited by research in Cancer Research (162 citations), Pulmonary and Respiratory Medicine (224 citations), Oncology (132 citations), Immunology (72 citations) and Molecular Biology (207 citations). Guowen Lin has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Yao Zhu, Bo Dai, Dingwei Ye, Xiaojian Qin, Junlong Wu, Guohai Shi, Yijun Shen, Wei Yu, Fangning Wan and Hailiang Zhang. Their work appears in journals such as The Prostate, Molecular Oncology, Scientific Reports, Cell Death Discovery and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.